The pathology of asthma: what is obstructing our view?

H Aegerter, BN Lambrecht - Annual Review of Pathology …, 2023 - annualreviews.org
Despite the advent of sophisticated and efficient new biologics to treat inflammation in
asthma, the disease persists. Even following treatment, many patients still experience the …

Advances and highlights in asthma in 2021

I Agache, I Eguiluz‐Gracia, C Cojanu, A Laculiceanu… - Allergy, 2021 - Wiley Online Library
Last year brought a significant advance in asthma management, unyielding to the pressure
of the pandemics. Novel key findings in asthma pathogenesis focus on the resident cell …

Expanding applications of pulmonary MRI in the clinical evaluation of lung disorders: Fleischner Society position paper

H Hatabu, Y Ohno, WB Gefter, G Parraga, B Madore… - Radiology, 2020 - pubs.rsna.org
Pulmonary MRI provides structural and quantitative functional images of the lungs without
ionizing radiation, but it has had limited clinical use due to low signal intensity from the lung …

[HTML][HTML] Biologics in severe asthma: a pragmatic approach for choosing the right treatment for the right patient

L Rogers, M Jesenak, L Bjermer, NA Hanania… - Respiratory …, 2023 - Elsevier
The development of monoclonal antibody therapies targeting specific components of the
pathways relevant to asthma pathophysiology has revolutionized treatment of severe …

Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD

KL Raby, C Michaeloudes, J Tonkin, KF Chung… - Frontiers in …, 2023 - frontiersin.org
The airway epithelium comprises of different cell types and acts as a physical barrier
preventing pathogens, including inhaled particles and microbes, from entering the lungs …

Dupilumab: Basic aspects and applications to allergic diseases

K Matsunaga, N Katoh, S Fujieda, K Izuhara… - Allergology …, 2020 - jstage.jst.go.jp
abstract Interleukin (IL)-4 and IL-13, signature type 2 cytokines, exert their actions by binding
to two types of receptors sharing the IL-4R a chain (IL-4Ra). Since IL-4 and IL-13 play …

Tezepelumab and mucus plugs in patients with moderate-to-severe asthma

LH Nordenmark, Å Hellqvist, C Emson, S Diver… - NEJM …, 2023 - evidence.nejm.org
Background Mucus plugs in asthmatic airways are associated with airway obstruction and
the activity of inflammatory cytokines, specifically interleukin (IL)-5 and IL-13, and they may …

[HTML][HTML] Asthma control, airway mucus, and 129Xe MRI ventilation after a single benralizumab dose

MJ McIntosh, HK Kooner, RL Eddy, S Jeimy, C Licskai… - Chest, 2022 - Elsevier
Background Patients with eosinophilic asthma often report poor symptomatic control and
quality of life. Anti-IL-5 therapy, including anti-IL-5Rα (benralizumab), rapidly depletes …

Mucus Plugs in Asthma at CT Associated with Regional Ventilation Defects at 3He MRI

DG Mummy, EM Dunican, KJ Carey, MD Evans… - Radiology, 2022 - pubs.rsna.org
Background Airway mucus plugs in asthma are associated with exacerbation frequency,
increased eosinophilia, and reduced lung function. The relationship between mucus plugs …

[HTML][HTML] In vivo methods and applications of xenon-129 magnetic resonance

H Marshall, NJ Stewart, HF Chan, M Rao… - Progress in Nuclear …, 2021 - Elsevier
Hyperpolarised gas lung MRI using xenon-129 can provide detailed 3D images of the
ventilated lung airspaces, and can be applied to quantify lung microstructure and detailed …